Related references
Note: Only part of the references are listed.Tumor Heterogeneity Revealed by KRAS, BRAF, and PIK3CA Pyrosequencing: KRAS and PIK3CA Intratumor Mutation Profile Differences and Their Therapeutic Implications
Vivian Kosmidou et al.
HUMAN MUTATION (2014)
Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity
Sebastien A. Smallwood et al.
NATURE METHODS (2014)
The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer
Wakkas Fadhil et al.
HISTOPATHOLOGY (2012)
Genetic heterogeneity and cancer drug resistance
Nicholas C. Turner et al.
LANCET ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes
Atsushi Kaneda et al.
CANCER SCIENCE (2011)
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
Wendy De Roock et al.
LANCET ONCOLOGY (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Molecular morphometric analysis shows relative intra-tumoural homogeneity for KRAS mutations in colorectal cancer
Liora Farber et al.
VIRCHOWS ARCHIV (2011)
Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing
Susan D. Richman et al.
ANALYTICAL CELLULAR PATHOLOGY (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Koichi Yagi et al.
CLINICAL CANCER RESEARCH (2010)
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
F. Molinari et al.
BRITISH JOURNAL OF CANCER (2009)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Susan D. Richman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
J. R. Jass
HISTOPATHOLOGY (2007)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)
Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma
B Baisse et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
